These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors. Yao MM, Joe BN, Sickles EA, Lee CS. Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413 [Abstract] [Full Text] [Related]
15. Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography. Kim EK, Ko KH, Oh KK, Kwak JY, You JK, Kim MJ, Park BW. AJR Am J Roentgenol; 2008 May; 190(5):1209-15. PubMed ID: 18430833 [Abstract] [Full Text] [Related]
16. False-negative rate of combined mammography and ultrasound for women with palpable breast masses. Chan CH, Coopey SB, Freer PE, Hughes KS. Breast Cancer Res Treat; 2015 Oct; 153(3):699-702. PubMed ID: 26341750 [Abstract] [Full Text] [Related]
17. Breast tomosynthesis for the clarification of mammographic BI-RADS 3 lesions can decrease follow-up examinations and enables immediate cancer diagnosis. Bahrs SD, Otto V, Hattermann V, Klumpp B, Hahn M, Nikolaou K, Siegmann-Luz K. Acta Radiol; 2018 Oct; 59(10):1176-1183. PubMed ID: 29451022 [Abstract] [Full Text] [Related]
19. [Performance of users in tropical areas with the BI-RADS classification of breast lesions for predicting malignancy]. Gonsu Kamga JE, Moifo B, Sando Z, Guegang Goudjou E, Nko'o Amvene S, Gonsu Fotsin J. Med Sante Trop; 2013 Oct; 23(4):439-44. PubMed ID: 24334372 [Abstract] [Full Text] [Related]